Author Affiliations: Department of Public Health and Community Medicine, University of Sydney, Australia (Drs Barratt, Irwig, and Cumming); Department of Social and Preventive Medicine, University of Queensland, Herston, Australia (Dr Glasziou); Avon Health Authority, Bristol, England (Dr Raffle); Oxfordshire Health Authority, Oxford, England (Dr Hicks); Institute of Health Sciences, University of Oxford, England (Dr Gray); and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario (Dr Guyatt).
Users' Guides to the Medical Literature Section
Editor: Drummond Rennie, MD, Deputy Editor (West), JAMA.
You are a family physician seeing a 47-year-old woman and her husband
of the same age. They are concerned because a friend recently found out
that she had bowel cancer and has urged them both to undergo screening
with fecal occult blood tests (FOBTs) because, she says, prevention is
much better than the cure she is now undergoing. Both your patients
have no family history of bowel cancer and no change in bowel habit.
They ask whether you agree that they should be screened.
Alexandra Barratt, Les Irwig, Paul Glasziou, Robert G. Cumming, Angela Raffle, Nicholas Hicks, J. A. Muir Gray, Gordon H. Guyatt, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical LiteratureXVII. How to Use Guidelines and Recommendations About Screening. JAMA. 1999;281(21):2029–2034. doi:10.1001/jama.281.21.2029